Analyst Viewpoint
Increase in usage of flowable hemostats in the partial splenectomy procedure is a primary factor responsible for the growth in the flowable hemostats market size. Flowable hemostats help control bleeding during the partial splenectomy procedure.
Rise in the elderly population is also fueling market progress. The geriatric population is at a greater risk of coronary heart disease, pneumonia, and osteoporosis, which need to be handled such that there is minimal blood loss during surgical treatment.
Flowable hemostats market manufacturers are offering evidence-based, data-driven optimization program based on hemostasis, which aims at curtailing intraoperative blood loss and reducing blood transfusions.
They are also entering into partnerships with hospitals in order to support these qualitative initiatives.
Flowable hemostats help stop bleeding by combining mechanical tamponade effect using hemostatic materials such as gelatin and injectable clotting agents such as thrombin. Fluid hemostatic sealants are absorbable dressings that close tissue and active sources of bleeding such as lymphatics and blood vessels.
Flowable hemostats are made from biologic materials such as lyophilized fibrinogen and thrombin or synthetic materials such as cyanoacrylates. They play a vital role in limited clotting/coagulation conditions.
Liquid hemostatic agents comprise 25% aluminum chloride to arrest gingival bleeding. They play a key role in managing bleeding during dental procedures.
Designing smart hemostatic materials that are capable of mimicking natural hemostatic processes is one of the emerging trends in flowable hemostatic solutions. For instance, fibrin-structured nanofibers facilitate platelet mimicking, which promotes formation of clot and contraction of the thrombus.
However, disadvantages associated with flowable hemostats, including side-effects such as vomiting sensation, nausea, difficulty in breathing, and headache, are hampering the flowable hemostats market value to a certain extent.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Partial splenectomy refers to the removal of 70% to 80% of splenic mass by surgery with the objective of reducing post-operative complications and preserving the splenic function.
Healthcare personnel are widely adopting flowable hemostats in the partial splenectomy procedure to control excessive bleeding during as well as post surgery.
Along these lines, thrombin-gelatin hemostatic matrix is recommended in hepatic surgeries, cardiovascular surgeries, and endoscopic sinus surgeries. Tranexamic acid-loaded starch microspheres are also likely to help with hemostatic stability.
Flowable hemostats such as Tisseel are also increasingly used during cardiopulmonary bypass, colostomy closure, splenic injury repair, and colonic anastomosis. It is the first fibrin sealant approved by the U.S. FDA.
Baxter International’s FLOSEAL Hemostatic Matrix is preferred over microporous polysaccharide powder materials. Introduction of such innovative products is propelling the flowable hemostats industry.
The WHO states that 1.5 billion people worldwide would be categorized as geriatric population by 2050.
The elderly population is more prone to various chronic diseases and also takes time to recover from traumatic accidents. Therefore, it is imperative to have measures in place to control bleeding with immediate effect in such patient pool.
Flowable hemostats are applied as a part of adjunct treatment for sealing residual oozing of the tissue tracts pertaining to femoral access sites to avoid excessive bleeding. They activate the clotting mechanisms of the body.
Growth in awareness about the benefits of timely usage of flowable hemostats in the geriatric population group is driving the flowable hemostats market.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest flowable hemostats market analysis, North America constituted the largest share of the global landscape in 2022. The region is projected to maintain its dominant position during the forecast period.
High flowable hemostats market share of North America can be ascribed to the rise in number of surgeries, availability of strong healthcare infrastructure, and presence of key players in the region, especially in the U.S.
Asia Pacific is also likely to record significant market development in the near future. Healthcare facilities in the region are increasingly focusing on delivery of superlative surgical treatments.
The cases of hemophilia have risen substantially in China. As per research conducted by Haemophilia Treatment Center Collaboration Network of China (HTCCNC), more than 18,000 individuals suffer from hemophilia.
Companies operating in the global flowable hemostats industry are engaging in new product launches to strengthen their market position. For instance, World Monopler Enterprises and Kenyon USA are introducing their flowable hemostats to compete with the established market players.
Existing players are emphasizing on mergers & acquisitions in order to increase their market share. For instance, in July 2021, Baxter International Inc. announced that it had completed the acquisition of CryoLife, Inc.
Johnson & Johnson, Baxter International, Inc., and Teleflex Incorporated are some of the leading players summarized in the flowable hemostats market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 716.8 Mn |
| Market Forecast (Value) in 2031 | US$ 1.4 Bn |
| Growth Rate (CAGR) | 7.7% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 716.8 Mn in 2022
It is projected to grow at a CAGR of 7.7% from 2023 to 2031
Increase in adoption of flowable hemostats in the partial splenectomy procedure and rise in geriatric population
The hospitals segment accounted for the largest share in 2022
North America was the dominant region in 2022
Johnson & Johnson, Baxter International, Inc., and Teleflex Incorporated
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Flowable Hemostats Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Flowable Hemostats Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Flowable Hemostats Market Analysis and Forecast, by Material
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Material, 2017–2031
6.3.1. Porcine Gelatin
6.3.2. Bovine Gelatin
6.4. Market Attractiveness Analysis, by Material
7. Global Flowable Hemostats Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. General Surgery
7.3.2. Cardiac Surgery
7.3.3. Vascular Surgery
7.3.4. Neuro & Spine Surgery
7.3.5. Orthopedic Surgery
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Flowable Hemostats Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Clinics
8.4. Market Attractiveness Analysis, by Application
9. Global Flowable Hemostats Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Flowable Hemostats Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Material, 2017–2031
10.3.1. Porcine Gelatin
10.3.2. Bovine Gelatin
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. General Surgery
10.4.2. Cardiac Surgery
10.4.3. Vascular Surgery
10.4.4. Neuro & Spine Surgery
10.4.5. Orthopedic Surgery
10.4.6. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Ambulatory Surgery Centers
10.5.3. Clinics
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Material
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Flowable Hemostats Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Material, 2017–2031
11.3.1. Porcine Gelatin
11.3.2. Bovine Gelatin
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. General Surgery
11.4.2. Cardiac Surgery
11.4.3. Vascular Surgery
11.4.4. Neuro & Spine Surgery
11.4.5. Orthopedic Surgery
11.4.6. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgery Centers
11.5.3. Clinics
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Material
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Flowable Hemostats Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Material, 2017–2031
12.3.1. Porcine Gelatin
12.3.2. Bovine Gelatin
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. General Surgery
12.4.2. Cardiac Surgery
12.4.3. Vascular Surgery
12.4.4. Neuro & Spine Surgery
12.4.5. Orthopedic Surgery
12.4.6. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgery Centers
12.5.3. Clinics
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Material
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Flowable Hemostats Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Material, 2017–2031
13.3.1. Porcine Gelatin
13.3.2. Bovine Gelatin
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. General Surgery
13.4.2. Cardiac Surgery
13.4.3. Vascular Surgery
13.4.4. Neuro & Spine Surgery
13.4.5. Orthopedic Surgery
13.4.6. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgery Centers
13.5.3. Clinics
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Material
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Flowable Hemostats Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Material, 2017–2031
14.3.1. Porcine Gelatin
14.3.2. Bovine Gelatin
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. General Surgery
14.4.2. Cardiac Surgery
14.4.3. Vascular Surgery
14.4.4. Neuro & Spine Surgery
14.4.5. Orthopedic Surgery
14.4.6. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgery Centers
14.5.3. Clinics
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Material
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Johnson & Johnson
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Baxter International, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Teleflex Incorporated
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
List of Tables
Table 01: Global Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031
Table 02: Global Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Flowable Hemostats Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Flowable Hemostats Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031
Table 07: North America Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Flowable Hemostats Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031
Table 11: Europe Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Flowable Hemostats Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031
Table 15: Asia Pacific Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Flowable Hemostats Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031
Table 19: Latin America Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast, by Material, 2017–2031
Table 23: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Flowable Hemostats Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Flowable Hemostats Market Revenue (US$ Mn), by Material, 2022
Figure 03: Global Flowable Hemostats Market Value Share, by Material, 2022
Figure 04: Global Flowable Hemostats Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Flowable Hemostats Market Value Share, by Application, 2022
Figure 06: Global Flowable Hemostats Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Flowable Hemostats Market Value Share, by End-user, 2022
Figure 08: Global Flowable Hemostats Market Value Share, by Region, 2022
Figure 09: Global Flowable Hemostats Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031
Figure 11: Global Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031
Figure 12: Global Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031
Figure 13: Global Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031
Figure 14: Global Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031
Figure 15: Global Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031
Figure 16: Global Flowable Hemostats Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Flowable Hemostats Market Attractiveness Analysis, by Region, 2023–2031
Figure 18: North America Flowable Hemostats Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Flowable Hemostats Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Flowable Hemostats Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031
Figure 22: North America Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031
Figure 23: North America Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031
Figure 24: North America Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031
Figure 25: North America Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031
Figure 26: North America Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Flowable Hemostats Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Flowable Hemostats Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Flowable Hemostats Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031
Figure 31: Europe Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031
Figure 32: Europe Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Europe Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031
Figure 34: Europe Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Europe Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Flowable Hemostats Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Flowable Hemostats Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Flowable Hemostats Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031
Figure 40: Asia Pacific Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031
Figure 41: Asia Pacific Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031
Figure 42: Asia Pacific Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031
Figure 43: Asia Pacific Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031
Figure 44: Asia Pacific Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Flowable Hemostats Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Flowable Hemostats Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Flowable Hemostats Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031
Figure 49: Latin America Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031
Figure 50: Latin America Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031
Figure 51: Latin America Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031
Figure 52: Latin America Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031
Figure 53: Latin America Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Flowable Hemostats Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Flowable Hemostats Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Flowable Hemostats Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Flowable Hemostats Market Value Share Analysis, by Material, 2022–2031
Figure 58: Middle East & Africa Flowable Hemostats Market Value Share Analysis, by Application, 2022–2031
Figure 59: Middle East & Africa Flowable Hemostats Market Value Share Analysis, by End-user, 2022–2031
Figure 60: Middle East & Africa Flowable Hemostats Market Attractiveness Analysis, by Material, 2023–2031
Figure 61: Middle East & Africa Flowable Hemostats Market Attractiveness Analysis, by Application, 2023–2031
Figure 62: Middle East & Africa Flowable Hemostats Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Flowable Hemostats Market
